Related Experiment Video
Updated: May 17, 2026
10:56
Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
Small molecules that target protein misfolding
Lori Krim Gavrin1, Rajiah Aldrin Denny, Eddine Saiah
1BioTherapeutics Chemistry, Pfizer Worldwide Medicinal Chemistry, 200 CambridgePark Drive, Cambridge, Massachusetts 02140, USA.
Journal of Medicinal Chemistry
|October 19, 2012
Summary
Small molecules can stabilize misfolded proteins, restoring their function and potentially treating diseases like Alzheimer's and Parkinson's. This approach offers a new therapeutic strategy for protein misfolding disorders.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Protein misfolding, where proteins lose their functional shape, is implicated in numerous diseases.
- Causes include genetic mutations and cellular stress (e.g., oxidative stress, pH changes).
- Associated diseases range from common neurodegenerative disorders to rarer conditions.
Purpose of the Study:
- To review small molecules designed to stabilize misfolded proteins.
- To explore therapeutic strategies for restoring protein function.
Main Methods:
- Literature review of small molecules targeting specific aberrant proteins.
- Discussion of stabilization mechanisms and functional restoration.
Main Results:
- Identified small molecules that bind to and stabilize misfolded proteins.
- Demonstrated potential for restoring native or near-native protein conformations.
- Highlighted therapeutic applications for various protein misfolding diseases.
Conclusions:
- Small molecule stabilization is a promising therapeutic approach for protein misfolding diseases.
- Targeting specific proteins like transthyretin, p53, and prions shows potential.
- Further research can advance treatments for debilitating conditions caused by protein misfolding.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:00Molecular Chaperones and Protein Folding
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
03:00Molecular Chaperones and Protein Folding
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
01:32Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
01:26Bacterial Protein Maturation
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...